. Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology. Brain. 2017 Jul 1;140(7):e40. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.